Project Grant R21EB038420
- The National Institute of Biomedical Imaging and Bioengineering awarded the Regents of the University of Michigan $149,264 on March 26, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop magnetic resonance fingerprinting (MRF) technology for myocardial tissue characterization in patients with cardiac implantable electronic devices. The project addresses the clinical underutilization of cardiac MRI in CIED...
- The National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded $199,991 to the Regents of the University of Michigan (doing business as University of Michigan-Dearborn) on May 15, 2026, under the Engineering Research Initiation program to design and build a microphysiological system that models cerebrospinal fluid dynamics in the brain to investigate mechanisms of neurodegeneration in Alzheimer's disease, Parkinson's disease, and amyotrophic...
- The National Institute of Biomedical Imaging and Bioengineering awarded the Regents of the University of Minnesota $1,073,800 on April 10, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop advanced radiofrequency and gradient technologies for whole-brain functional and structural connectivity mapping at 10.5T MRI. The work addresses suboptimal RF and gradient technologies that limit the 10.5T scanner's capability...
- The National Institute on Aging awarded Michigan State University (doing business as Henry Ford Health+Michigan State University Health Sciences) $314,000 on April 1, 2026, under the Aging Research program (CFDA 93.866) to optimize and validate detection and modeling of the vascular and glymphatic systems in cerebral waste clearance using superparamagnetic iron oxide-enhanced susceptibility weighted imaging (SPIO-SWI), and to investigate cerebral waste clearance changes during Alzheimer's...
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of Wisconsin - Madison $611,597 on June 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop next-generation, confounder-corrected magnetic resonance imaging-based intra-voxel incoherent motion (IVIM) methods for simultaneous quantification of blood perfusion and tissue microstructure. The research addresses current limitations...
- The National Institute of Biomedical Imaging and Bioengineering awarded the Regents of the University of Minnesota $209,940 on June 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a portable phase-only parallel transmission interface for enhancing phosphorus-31 magnetic resonance spectroscopy imaging at 7 Tesla. The recipient will design and build a digital-controlled, RF broadband interface that adjusts...
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of Maryland, Baltimore $516,628 on June 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop motion correction techniques for single-shot diffusion-weighted MRI of the brain. The project will create a suite of real-time motion correction techniques using two novel MR-based navigators and improved reconstruction of raw...
- The National Institute of Biomedical Imaging and Bioengineering awarded The Research Foundation For The State University Of New York (operating as Stony Brook University) $194,819 on August 15, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop and validate a noninvasive imaging framework that integrates fast tagging MRI with deep-learning based pattern recognition to quantify low-frequency cerebrospinal fluid...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded a $3.06M Project Grant to Henry Ford Health+Michigan State University Health Sciences on September 15, 2025, under the Aging Research program (CFDA 93.866) to support a four-year research initiative through August 31, 2029. The award funds research directed toward optimizing and validating advanced neuroimaging detection methods for cerebral waste clearance pathways during Alzheimer's disease progression. The...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded $762,423 to the Regents of the University of Michigan on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and optimize quantitative magnetic resonance fingerprinting (MRF) technology for non-invasive assessment of bladder wall tissue characteristics in neurogenic lower urinary tract dysfunction. The research addresses limitations of current...
The National Institute of Biomedical Imaging and Bioengineering awarded the Regents of the University of Michigan $184,468 on August 19, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop and validate a magnetic resonance imaging technique for measuring water velocity distribution in brain tissue. The project addresses impaired glymphatic clearance in neurodegenerative diseases including Alzheimer's, Parkinson's, and vascular dementia. The research develops a non-invasive MR imaging method using modified velocity-selective radiofrequency pulses to obtain three-dimensional velocity vector distributions of convective flow in each voxel, enabling unprecedented detail in measuring water movement through brain tissue. The work proceeds in three phases: development and validation on flow phantoms with known characteristics, reproducibility measurement in human participants under hypercapnia and caffeine challenges, and establishment of normative velocity distributions by age and sex in healthy participants to serve as reference for future pathological studies. Performance occurs in Ann Arbor, Michigan. The period of performance runs through July 31, 2028. The project grant assistance type funds hypothesis- and technology-driven research into discovery, design, development, validation, and application of biomedical imaging and bioengineering technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $184.5k | 8/18/26 |